As of Jul 25
| -0.13 / -0.78%|
The 9 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 45.00, with a high estimate of 55.00 and a low estimate of 30.00. The median estimate represents a +172.40% increase from the last price of 16.52.
The current consensus among 9 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.